Jeff Sharman, MD Medical Director of Hematology Research for US Oncology talks about how CLL has been Transformed in Last 5 Years and that the Hope is to Leave Chemotherapy Behind
Jeff Sharman, MD Medical Director of Hematology Research for US Oncology talks about how CLL has been Transformed in Last 5 Years and that the Hope is to Leave Chemotherapy Behind